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Abstract
Background: Hip and knee replacement are effective procedures for end-stage arthritis that has not responded to
medical management. However, until now, there have been no validated, patient-reported tools to measure early
recovery in this growing patient population. The process of development and psychometric evaluation of the
Oxford Arthroplasty Early Recovery Score (OARS), a 14-item patient-reported outcome measure (PROM) measuring
health status, and the Oxford Arthroplasty Early Change Score (OACS) a 14-item measure to assess change during
the first 6 weeks following surgery is reported.
Patients and methods: A five-phased, best practice, iterative approach was used. From a literature based starting
point, qualitative interviews with orthopaedic healthcare professionals, were then performed ascertaining if and
how clinicians would use such a PROM and change measure. Analysis of in-depth patient-interviews in phase one
identified important patient-reported factors in early recovery which were used to provide questionnaire themes. In
Phase two, candidate items from Phase One interviews were generated and pilot questionnaires developed and
tested. Exploratory factor analysis with item reduction and final testing of the questionnaires was performed in
phase three. Phase Four involved validation testing.
Results: Qualitative interviews (n = 22) with orthopaedic healthcare professionals, helped determine views of
potential users, and guide structure. In Phase One, factors from patient interviews (n = 30) were used to find
questionnaire themes and generate items. Pilot questionnaires were developed and tested in Phase Two. Items
were refined in the context of cognitive debrief interviews (n = 34) for potential inclusion in the final tools. Final
testing of questionnaire properties with item reduction (n = 168) was carried out in phase three. Validation of the
OARS and OACS was performed in phase four. Both measures were administered to consecutive patients (n = 155)
in an independent cohort. Validity and reliability were assessed. Psychometric testing showed positive results, in
terms of internal consistency and sensitivity to change, content validity and relevance to patients and clinicians. In
addition, these measures have been found to be acceptable to patients throughout early recovery with validation
across the 6 week period.
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Conclusions: These brief, easy-to-use tools could be of great use in assessing recovery pathways and interventions
in arthroplasty surgery.
Keywords: Early recovery, Postoperative, Knee arthroplasty, Hip arthroplasty, Patient-reported outcome measure,
Questionnaire, Food and Drug Administration (FDA), Validity, Reliability
Background
The incidence of arthritis is increasing [1]. The World
Health Organisation (WHO) has identified arthritis as one
of the top ten disabling conditions. As the number of
people experiencing arthritis increases, thus the number
of patients requiring surgical intervention increases. It is
estimated that approximately 200,000 hip and knee re-
placements are performed in the United Kingdom (UK)
annually [2], with the number being 1 million in the
United States (US) [3, 4]. This number is anticipated to
continue to grow significantly over the next 10 years [5].
Despite increases in the frequency of this procedure, the
way we measure recovery has not changed in recent years.
Optimising perioperative recovery is critical to en-
hance patient care, ensure timely discharge from the pa-
tient, clinician and hospital perspective and improve
short and long-term outcomes after surgery [6]. How-
ever, until now, there has been debate about how to
measure recovery with previously used measures in early
recovery not patient-reported.
Prior to commencing this study, a systematic literature
review was performed to evaluate the need for an early re-
covery PROM or change measure in this patient popula-
tion [7]. The most important finding from this review is
that whilst 15 instruments were identified to assess post-
operative recovery, none were found to fulfil all quality
criteria [8] and be valid for assessing early postoperative
recovery in the hip or knee arthroplasty population. This
specifically revealed that previously used measures were
found to be inappropriate to accurately evaluate the qual-
ity of recovery and lacked precision. Only seven out of the
15 instruments included any orthopaedic patients in their
development. Within those seven, less than 15% of those
patients were orthopaedic. Thus limiting the applicability
of these instruments as it is likely that recovery factors im-
portant to patients undergoing orthopaedic surgery are
significantly different to recovery factors in patients
undergoing other types of surgery. Being able to measure
patient-reported outcomes following arthroplasty could be
of great benefit in clinical trials involving medication, care
pathways and implant selection. It could also potentially
work to optimise routine care by allowing provision of ap-
propriate, safe, timely care and interventions.
The process of development for a PROM and a meas-
ure to determine postoperative change since surgery was
therefore begun with initial qualitative work being
performed to facilitate concept understanding and item
generation. The Food and Drug Administration (FDA)
guidelines [9] provide a thorough outline by which new
patient-reported outcome measures (PROMs) should be
developed. Item generation comes directly from patient
statements and from the patient population the tools are
being designed to serve. Throughout the entire process
including item generation, selection of candidate items,
wording changes and item reduction, a detailed item
tracking matrix was maintained. The item tracking
matrix provides ease of identification in item modifica-
tions, direct patient sources, and a record of item
deletions.
Methods and phases
The Oxford Arthroplasty Early Recovery Score (OARS)
and the Oxford Arthroplasty Early Change Score
(OACS) were developed and tested through mixed
methods research study and was carried out across two
stages (five phases) in strict accordance the Food and
Drug Administration (FDA) guide [9] for best practice
in PROM development (Fig. 1).
Stage one: item generation and initial questionnaire
development
Planning phase
The initial planning phase, consisted of exploratory
semi-structured interviews (n = 22) to explore ortho-
paedic healthcare professionals’ experience and perspec-
tive of early recovery for patients undergoing total hip
arthroplasty (THA) or total knee arthroplasty (TKA).
These were used to guide structure and layout of the
questionnaires.
Design
In the planning phase interviews, semi-structured inter-
views were utilised to explore the experience and per-
spective of the early recovery period by healthcare
providers caring for patients undergoing THA or TKA.
These interviews, were guided by a list of interview
prompts, which facilitated further exploration of areas of
the topic that need to be covered by the interviewer
[10]. The interview guides were standardised and con-
sisted of open-ended questions and prompts. These were
developed by the research team and patient partners.
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Analysis
An in-depth pragmatic thematic analysis method [11]
was utilised. Thematic analysis facilitates identification
of themes or commonalities in interview transcripts. It
helps organise and understand data. In this research de-
veloping a patient-reported recovery measure, it is im-
portant to fully explore and understand the themes that
are of importance in postoperative arthroplasty recovery
for patients and healthcare providers. These interviews
provided background and clinician perspective to the
possible new PROM.
Phase one
Phase one of the study, patients undergoing THA or
TKA were interviewed (n = 30) during the early peri-
operative period between the day of surgery and
discharge from the surgeons care between 6 and 8
weeks. A conceptual model was utilised when developing
the new tools [12]. In addition, results from the phase
one qualitative findings were considered for making de-
cisions about item reduction.
Design
Phase one interviews, consisted of semi-structured inter-
views to explore the experience and perspective of patients
during the early recovery period undergoing THA or
TKA. These interviews, were guided by a list of interview
prompts, which facilitated further exploration of areas of
the topic that need to be covered by the interviewer [10].
The interview guides were standardised and consisted of
open-ended questions and prompts. These were devel-
oped by the research team and patient partners.
Fig. 1 Study stages and phases
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Analysis
As in the planning phase, an in-depth pragmatic the-
matic analysis method [11] was utilised. Thematic ana-
lysis facilitates identification of themes or commonalities
in interview transcripts. It helps organise and understand
data. Coding is the technique by which themes are iden-
tified and organised. This method of analysis was chosen
for several reasons. It was vital for this research develop-
ing a patient-reported recovery measure to fully explore
and understand the themes that are of importance in
postoperative arthroplasty recovery for patients and
healthcare providers. As the tool was being designed for
use in both clinical and home settings (the latter after
discharge), the tool needed to be meaningful and effect-
ive in a real world setting [13]. Following immediate
exact word-for-word transcription, interviews were
anonymised to remove any participant identifiable data.
These transcribed interviews were then imported into
NVivo software (NVivo qualitative data analysis Soft-
ware; QSR International Pty Ltd. Version 11, 2015) and
analysis performed. Themes that were important to pa-
tients undergoing hip or knee replacement were re-
corded. This process is known as coding in qualitative
research [14]. Initial coding of the interviews was per-
formed independently by two reviewers, the researcher
and an expert colleague in qualitative research, to ensure
thorough coverage of the work. Interviews were coded
based on the patients’ words and context. The interviews
were analysed in an iterative ongoing basis. This tech-
nique is designed to elucidate any new themes that may
emerge as the study is being performed and allows for
the iterative process of interview adaptation to occur. If
any new areas come to light during the earlier inter-
views, they can be added into subsequent interviews as
interview prompts. This too helps to ensure full coverage
of the concept being explored [13]. The sample size for
participants was guided by data saturation [15, 16] which
is the time at which subsequent interviews did not pro-
duce any new themes. Interviews were coded based on
the participants’ words and context. This important part
of the analysis was performed independently by two re-
searchers and discussed. Any unresolved concerns were
taken to a third researcher for further resolution.
Item generation came directly from patient statements
and from the patient population the tools are being de-
signed to serve. Following thematic analysis and coding
of the qualitative interviews, a list of potential sample
items were created for each theme. These statements in-
cluded items from all patient interviews and all themes
from the Phase One analyses. These were reviewed by
the expert and patient panel which included two sur-
geons, two nurses, an anaesthetist, two hip and knee
arthroplasty patients, a psychometrician with a particular
interest in patient related outcomes, and one patient
caregiver. The purpose of this panel was to review and
evaluate potential items. In addition, ideas and sugges-
tions for layout and response options were also
discussed.
Phase two
The first iteration of the OARS contained 18 items. The
items in this PROM covered all aspects of the early re-
covery period. The first iteration of the OACS contained
25 items. This change measure included items designed
to cover the concepts of early recovery and the change
that may occur during the first 6 weeks. The items cov-
ered all themes reported by patients.
Design
The candidate questionnaires were tested once during
the patients’ hospital stay and cognitive debrief inter-
views (n = 34) were used to assess items for face and
content validity. Validity of an outcome measure is the
extent to which it measures what it claims to measure.
This is assessed through consideration and evaluation of
several different aspects, including content and construct
validity [17]. Changes were made accordingly to the
questionnaire.
Analysis
Patients were requested to complete the questionnaire
in the context of cognitive debriefing. These techniques
allow the interviewer to determine the meaning a par-
ticipant gives to questions and why they selected par-
ticular response options [9, 18]. All participants received
both the OARS and OACS at the time of testing. These
draft questionnaires were administered once to 34 pa-
tients in the early postoperative period during hospital-
isation (days 0 to 8). The participants were then asked to
discuss the items, the reason for their answers and the
meaning they attributed to them. During these inter-
views, participants were asked to discuss how thorough
they felt coverage was of the topic of recovery after TKA
or THA. In addition, they were asked if the questions
were easily understandable and if they were relevant to
their particular situation. These interviews were audio
recorded and transcribed verbatim. This led to the first
version of test questionnaires being developed that were
refined in the following phases.
Prior to testing, a translatability assessment (TA) was
performed on the two new measures. TA has been recog-
nised as an important part of the questionnaire develop-
ment process [9]. It provides insight into what extent the
items in the questionnaires can be translated into other
languages [19]. This is of particular importance for use in
cross cultural trials. Changes may be made to the wording
of some items as a consequence of this procedure. In
addition, a concept elaboration document (CED) was
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created to fully define and clarify question items and the
meanings attributed to them. This was developed in com-
bination with the author [20] and specialist translators, to
provide specific detail regarding the explicit line-by-line
meaning of items and concepts, providing clarification of
each line of the questionnaire [21].
Stage two: item reduction and scale generation. Testing
reliability and validity
Phase three
Final questionnaire development and testing was per-
formed in phase three.
Design
Patients (n = 168) were given questionnaires on days 1,2,
3,7,14 and 6 weeks following either hip or knee replace-
ment surgery. They were administered on days 1, 2, 3, 7
and 14 in the early postoperative period and also at 6
weeks following surgery. Exploratory factor analysis
(EFA) was used to explore the dataset and determine
what latent underlying constructs are being measured
[22]. EFA evaluates the scale properties and aids in re-
moving non-response level or are not internally consist-
ent [23, 24]. All of the items for the OARS and OACS
were put into a factor analytic model (Varimax with Kai-
ser Rotation). Varimax rotation was selected as it facili-
tates data pattern interpretation. EFA was performed on
the most populous time point (day 1 testing). Only fac-
tors which gained an eigenvalue of > 1 were retained. Se-
lection and decision making on the number of factors to
be retained can be determined by multiple means of
testing including eigenvalues and factor loadings [25]. In
participants who were discharged prior to day three,
questionnaires with stamped self-addressed envelopes
were provided. The specific testing time points were
chosen to maximise the information acquired from par-
ticipants and also to provide thorough coverage of the
early recovery period.
Analysis
In phase three, both exploratory factor analysis and item
reduction were performed using SPSS 25 software. Kaiser-
Meyer-Olkin Measure of Sampling Adequacy (KMO) and
Bartlett’s Test of Sphericity tests were performed to deter-
mine if the data was appropriate for factor analysis. Fre-
quency tables were created and examined for floor and
ceiling effects. An initial principal component analysis
(PCA) was undertaken to determine if any of the items
were not suitable for analysis or outliers. This process
sorts variables into factors and indexes the amount of vari-
ance from each. This number is called the eigenvalue and,
as previously mentioned, values above one are considered
statistically significant and meaningful. Descriptive statis-
tics and frequency tables reported. Exploratory factor
analysis (EFA) was carried out on the most populous time
point to determine what constructs underlie the data and
to determine redundancy in any of the items. PCA with
Varimax rotation was performed on days 1, 7, 14 and at 6
weeks. PCA is utilised to reduce the data into a smaller
number of components. Varimax rotation was selected as
it facilitates data pattern interpretation. Item reduction
was reported. In this group, those with stronger factor
correlations (above 0.5) are considered to have loaded on
those factors [26]. The weaker, or non-loading, items can
then be considered for removal. Internal consistency was
also reported using the alpha statistic, known as Cron-
bach’s alpha, indicates the extent to which there is a pat-
tern of responses to items. It is a commonly used
statistical test for this purpose [27], with scores above 0.7
considered acceptable.
Phase four
Validation of questionnaires responsiveness and sensitiv-
ity to change were measured in phase four. These are
important, closely related qualities in validating outcome
measures, particularly if they are potentially being used
in clinical decision making and trials [28]. The results
from the OARS and OACS were evaluated for respon-
siveness, a measure’s ability to detect clinically important
changes and sensitivity to change over time, a statistical
feature of a measure. The initial testing time point was
measured and compared with the means of additional
testing points through 6 weeks. Construct validity is the
extent to which a questionnaire measures what it claims
to measure [29]. Comparison and correlation of the pre-
viously hypothesised dimensions of the SF-36v2 were
made in relation to the new OARS to assess construct
validity [29].
Design
The two final questionnaire versions were distributed to
consecutive patients (n = 155) in a cohort of hip and
knee replacement patients. They were again adminis-
tered on days 1, 2, 3, 7 and 14 and also at 6 weeks fol-
lowing surgery. In addition a widely used, validated,
generic health measure the Short Form-36 version 2
Acute (SF-36v2), United Kingdom (English) [30] was
given to participants on days 7, 14 and 6 weeks. This
self-administered questionnaire covers eight domains of
both physical and mental health and has been used dur-
ing the validation of other disease specific health mea-
sures across a wide range of conditions [31, 32]. The SF-
36v2 Acute has a recall period of 1 week and therefore
made it appropriate for use in evaluating the new OARS
and OACS. Prior hypotheses for correlations were con-
sidered. These included that the highest correlations
would be found between OARS domains and SF-36 v2
Acute dimensions between the following: OARS pain
Strickland et al. Journal of Patient-Reported Outcomes            (2020) 4:91 Page 5 of 17
with the SF-36v2 Acute bodily pain; OARS nausea and
feeling unwell with SF-36v2 Acute domain of general
health; OARS fatigue and sleep with SF-36v2 Acute vi-
tality; and OARS improving function and mobility with
SF-36v2 Acute physical functioning.
Analysis
In phase four, validation and reliability was tested in-
cluding scale generation and testing scale properties, de-
scriptive statistics and frequency tables, internal
consistency and construct validity. The SF-36, a previ-
ously validated generic health measure, was administered
alongside the newly developed OARS and OACS to pro-
vide comparison and correlation for construct validity
for the new measures. In addition, responsiveness and
sensitivity to change were reported. The initial testing
time point was measured and compared with the means
of additional testing points through 6 weeks.
SPSS 25 software was used for analyses in phases three
and four (IBM Corp. Released 2017. IBM SPSS Statistics
for Windows, Version 25.0. Armonk, NY: IBM Corp.).
Recommended scoring algorithms were utilised for the
SF-36v2 (Quality Metric Health Outcomes™ Scoring
Software 5.0; 2016).
Sample size calculations and considerations
In testing of psychometric properties, larger samples are
often considered desirable [33]. Sample sizes based on
five to ten times the number of respondents as items are
often quoted in the literature [34, 35]. This guideline




Participant demographic and surgical characteristics for
each of the study phases are presented in Table 1. The
planning phase participants are presented in Table 2.
Participants ranged in age from 20 to 92 years of age.
These participants represented a range of ethnicities,
Table 1 Participant characteristics
Stages Stage One: Item generation and initial questionnaire
development
Stage Two: Item reduction and scale generation. Testing
reliability and validity
Parameter/Study phase Phase One Phase Two Phase Three Phase Four
Age (years) 71.0 (10.3) 45–92 67 (11.3) 50–81 66.1 (9.9) 38–87 68 (10.9) 20–87
Sex Male/Female (% male) 14/16 (46.7) 16/18 (47) 71/97 (42) 65/90 (42)
Ethnicity WB 28 (93.3) WB 32 (94.1) WB 157 (93.5) WB 151 (97.4)
OW 2 (6.7) OW 2 (5.9) OW 7 (4.2) OW 1 (0.6)
WI 2 (1.2) I 1 (0.6)
Af 1 (0.6) Ar 1 (0.6)
OA 1 (0.6) C 1 (0.6)
Duration of disease (years) 4.6 (4.1) 0.67–20 4.4 (4.2) 0.5–30 6.2 (6.8) 0.5–43 6.2 (9.3) 0.5–74
Length of stay (days) 28.5 (24.0) 0–63 3.15 (2.83) 0–8 2.3 (2.5) 0–15 2.6 (2.7) 0–21
Type of surgery THA 16 (53.3) THA 9 (26) THA 70 (41.7) THA 58 (37.4)
TKA 11 (36.7) TKA 9 (26) TKA 26 (15.5) TKA 33 (21.3)
UKA 2 (6.7) UKA 12 (35) UKA 54 (32.1) UKA 55 (35.5)
Rev. THA 1 (3.3) Rev. THA 1 (3) PFJ 2 (1.2) Rev. THA 6 (3.9)
Rev. TKA 3 (9) Rev. THA 7 (4.2) Rev. TKA 3 (1.9)
Rev. UKA/TKA 9 (5.4)
Employment Employed 7 (23.3) Employed 16 (47) Employed 67 (39.9) Employed 38 (24.5)
Retired 21 (70) Retired 18 (53) Retired 91 (54.2) Retired 110 (71)
Disabled 2 (6.7) Disabled 10 (5.9) Disabled 7 (4.5)
Living situation Alone 6 (20) Alone 8 (24) Alone 41 (24.4) Alone 27 (17.4)
Family 24 (80) Family 26 (76) Family 127 (75.6) Family 128 (82.6)
Home situation One level 4 (13.3) One level 6 (18) One level 37 (22) One level 20 (12.9)
Up and down stairs 26 (86.7) Up and down stairs 28 (82) Up and down stairs 131 (78) Up and down stairs 135 (87.1)
Data are n (%) or mean (SD) range. Ethnicity: WB White British, OW Other White, WI White Irish, Af African, OA Other Asian, I Indian, Ar Arabic, C Caribbean.
Ethnicity categories from Office for National Statistics (ONS), Census 2011. Type of surgery: THA Total Hip Arthroplasty, TKA Total Knee Arthroplasty, UKA
Unicompartmental Knee Arthroplasty, PFJ Patellofemoral Joint Replacement, Rev. THA Revision Total Hip Arthroplasty, Rev. UKA/ TKA Revision Unicompartmental
Knee Arthroplasty/Total Knee Arthroplasty, Rev. TKA Revision Total Knee Arthroplasty
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duration of diseases and lower limb joint replacements.
In the planning phase, these participants represented a
range of healthcare careers, and years of experience car-
ing for orthopaedic patients undergoing lower limb joint
replacement.
Conceptual framework
The development of a conceptual model or theoretical
underpinning is essential when developing a new tool
[12]. This framework was developed from the qualitative
work in both the Planning Phase and Phase One inter-
view analyses (Table 3). It provided a necessary frame-
work around which the items and purpose of the
questionnaire could be prepared. In the development of
a PROM, or change measure, content validity is an es-
sential component, as it ensures that the constructs of
the topic, in these aspects of recovery from joint replace-
ment surgery, are covered by the measure.
By utilising both patient data and an expert group of
healthcare providers, this not only strengthened the ro-
bustness of the tool, but also ensured that it would make
sense in the clinical setting in which it would be used.
Whilst expert opinion aided the development of the
semi-structured interview schedule, the items were gen-
erated solely on the basis of patient reports in Phase
One of the study. Existing literature in the field was also
consulted to reinforce the model.
Stage one: item generation and initial questionnaire
development
Planning phase
A total of 22 participants were included in the study
(Table 2). All have been working in the care of the
arthroplasty patient for an average of 16.4 years (SD =
9.2). All participants work in the same Orthopaedic hos-
pital setting.
Three main themes evolved from the interviews and
were mentioned by all interviewees: immediate recovery
issues (n = 22), discharge criteria (n = 22), and priorities
during hospitalisation from healthcare providers’ per-
spective (n = 22).
Phase one
Thirty patients receiving with hip or knee joint replace-
ment surgery were recruited to phase one of study
(Table 1). All participants were recruited in the same
orthopaedic hospital. The duration of disease ranged
from 0.67 years to 20 years (mean = 4.6; SD = 4.1).
Seven main themes evolved from the interviews and
were discussed by all participants: ‘improving function
and mobility’ (n = 30), ‘pain’ (n = 30), ‘effects of health-
care on outcomes’ (n = 30), ‘support from others’ (n =
30), ‘involvement and understanding of care decisions’
(n = 30), ‘behaviour and coping’ (n = 30) and ‘fatigue and
sleeping’ (n = 30).
Phase one patient interviews provided statements for
potential inclusion as items in the pilot questionnaires
to be tested in phase two. Initially 136 statements were
drafted for consideration. These draft statements were
approved by the expert and patient panel to be evaluated
in Phase Two. From this list of patient statements, be-
tween six and 12 were chosen by the panel for each the-
matic area. These covered recovery topics in full and
Table 2 Planning phase participant characteristics
Stages
Parameter






Ethnicity Arab 1 (4.5)
White British 14 (63.6)
African 1 (4.5)
Indian 1 (4.5)
Other White 4 (18.2)
Irish 1 (4.5)
Employment role Registered Nurse 5 (22.7)
Orthopaedic Surgeon 5 (22.7)
Anaesthetist 5 (22.7)
Physical Therapist 5 (22.7)
Occupational Therapist 2 (9.1)
Length of time in
career (years)
16.4 (9.2) 1–35
Sub Group Number Sex
Male/
Female
Ethnicity Length of time in
career (years)

























Data are n (%) or mean (SD) range. Ethnicity categories from Office for
National Statistics (ONS), Census 2011
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were intended to be sensitive to changes following sur-
gery. By discussion and exploration of the draft state-
ments, it was determined that the items would be
separated into two patient-reported questionnaires: one
PROM and one change measure. Therefore the Oxford
Arthroplasty Early Recovery Score (OARS) and Oxford
Arthroplasty Early Change Score (OACS) were devel-
oped. Tables 4 and 5 show the pilot OARS and OACS
items, themes and participant IDs. Healthcare profes-
sionals stated that these could be of great use in the clin-
ical area. Patients had expressed interest in seeing how
things had changed, and hopefully improved, since
surgery.
The OARS and OACS evolved through multiple itera-
tions prior to their completion for use in Phase Two.
Careful consideration was given throughout to both the
items themselves and to the answer response options.
The wording rubric and instructions for completion also
developed and improved through this process. Some
themes were removed from the item selection pool be-
cause they related more to experiences than recovery
and quality of life. Future work may incorporate an ex-
periences questionnaire, but this was out with the scope
of this study.
Phase two
A total of 34 participants were included in phase two of
the study (Table 1). The duration of disease ranged from
0.5 years to 30 years (mean = 4.4; SD = 4.2). Overall pa-
tients liked the questions and layout of the OARS and
OACS. Cognitive debrief interviews (n = 34) were used
to assess items for face and content validity.
‘It was easy to fill in and they are all questions that
are relevant’ (Participant 6).
When asked if the questions made sense or if any were
confusing, patients again appeared to be happy with the
content and wording.
‘They all made sense yeah’ (Participant 22).
‘They were dead easy and straight forward’ (Partici-
pant 30).
Patients were asked if there were any additional ques-
tions they would like to have been asked or if they felt
anything had been omitted.
‘I think it covered most bases. The questions them-
selves were good questions, yes’ (Participant 8).
‘I might on reflection think of something else but at
the moment I would have said that, that was fine’
(Participant 11).
Table 3 Conceptual framework
































Fatigue and sleep Feeling tired
Not sleeping well
Difficulty sleeping
















Giving you what they
think you need
Behaviour/ coping Putting up with it
Knowing my
capabilities
Listening to what you
are being told
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‘I don’t think there was anything (missing). I think
you pretty well covered everything. No I don’t think
so’ (Participant 15).
Item 13 in the OARS (Table 4) contained two answer
options as both had been expressed by patients. The an-
swer options were 13a: I found it quite hard to sleep and
13b: I have found it difficult to sleep. Patients in phase
two had a preference for 13b so that was selected for in-
clusion in the Phase Three OARS.
Following feedback from participants in phase two,
four items were removed from the OACS:
 Item 3. Your movement compared to prior to the
operation?-Seen as a duplicate to item 2: Ability to
move compared to prior to the operation?
 Items 9. Your pain compared to prior to the
operation? And Item 10. How you feel today as
compared to prior to the operation?-Disliked by
patients as seen as too similar to other questions
 Item 17. The amount of pain killers you need to
take as compared to prior to the operation?-Too
ambiguous per patients
Patients in the midst of an experience of immediate
postoperative issues were able to elicit direct responses
to the pilot items in the PROM and change measure
during their hospital stay. These ideas were confirmed
by the expert panel of healthcare professionals. The
opinions from patients on the timing, wording of items
and the answer options, provided essential feedback
which shaped the next version of both the OARS and
OACS questionnaires for testing and validation in the
subsequent phases.
As patients were only administered the questionnaires
once during this phase, they reported being keen to test
the OARS and OACS at different time points and see if
they would answer differently. This response was posi-
tive as the measures will be tested and validated over dif-
ferent time points during the recovery period in the next
phases.
Stage two: item reduction and scale generation. Testing
reliability and validity
Phase three
Out of 168 participants, 161 returned their questionnaires
at time point one (day 1 postoperatively) (missing n = 7,
4.2%). Before principle component analysis (PCA) was
performed, KMO and Bartlett’s test of sphericity were per-
formed to determine the suitability of the data for factor
analysis. These appeared favourable for both the OARS
and OACS with KMO .835 and .936 respectively and Bar-
tlett’s test of significance .001. Consequently the data from
Table 4 Pilot OARS items and themes breakdowns
Phase Two OARS Item Theme Participant ID
1. I have felt unwell Effects of healthcare on outcomes 2, 11
2. I have felt disorientated Effects of healthcare on outcomes 11, 18
3. I have felt tired Fatigue and sleep 14
4. I have felt faint Pain 18
5. It has been quite painful Pain 3, 11, 13, 25
6. I have had constant pain Pain 13
7. I have worse pain at night Pain 13
8. It has felt swollen Pain 10, 13, 26
9. I have difficulty getting into bed Improving function and mobility 8
10. I am not able to stand Improving function and mobility 11
11. I am not able to walk Improving function and mobility 11
12. I have not slept well Fatigue and sleep 18, 26
Which question 13a or 13b do you prefer?
13a. I have found it quite hard to sleep
or
13b. I have found it difficult to sleep
Fatigue and sleep 6, 21
14. I have not been able to sleep due to the pain Fatigue and sleep 30
15. I have felt sick Effects of healthcare on outcomes 2, 4, 11, 13, 17, 18, 20, 21, 23, 24, 26
16. I have felt woozy Effects of healthcare on outcomes 4
17. I have been constipated Effects of healthcare on outcomes 13, 23, 24
18. I have lost my appetite Effects of healthcare on outcomes 2, 24, 25
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both measures appeared amenable to factor analytic
techniques.
Oxford arthroplasty early recovery score (OARS)
EFA indicated that over 64% of the variance could be ex-
plained by four factors. Upon analysis of the data over
35% of the variance was explained by one factor. The
eigenvalue for the first factor was 6.398. The second
factor explained over 12% of the variance (eigenvalue
2.238). The remaining two factors explained 9.7% and
7% of the variance respectively. Both had eigenvalues
over 1.
Inspection of the items suggested that the factors were
tapping aspects of pain, sleep, nausea and feeling unwell,
and mobility respectively (Table 6).
Table 5 Pilot OACS items and themes breakdowns
Phase Two OACS Item Theme Participant ID
1. Your ability to stand compared to prior to the operation? Improving function and
mobility
11
2. Your ability to move compared to prior to the operation? Improving function and
mobility
1, 3, 8, 16
3. Your movement compared to prior to the operation? Improving function and
mobility
7, 19, 30
4. Your mobility compared to prior to the operation? Improving function and
mobility
13
5. Your ability to walk compared to prior to the operation? Improving function and
mobility
3, 15, 16, 27
6. Your ability to go upstairs compared to prior to the operation? Improving function and
mobility
1, 5, 7, 17, 22, 27, 28
7. Your ability to go down stairs compared to prior to the operation? Improving function and
mobility
1, 5, 7, 17, 22, 27, 28
8. Your strength compared to prior to the operation? Improving function and
mobility
20, 30
9. Your pain compared to prior to the operation? Pain 2, 5, 6, 9, 12, 13, 14, 15, 18, 19, 20, 21, 23, 24,
29, 30
10. How you feel today as compared to prior to the operation? Pain 9, 10, 25, 27
11. How comfortable you feel today compared to prior to the
operation?
Pain 7, 10, 30
12. Your pain when walking as compared to prior to the operation? Pain 2, 5, 6, 8, 9, 12, 13, 14, 15, 17, 18, 19, 20, 21, 23,
24, 29, 30
13. Your pain in the joint today compared to prior to the operation? Pain 18, 30
14. Your pain at night compared to prior to the operation? Pain 20
15. Your pain when getting into bed compared to prior to the
operation?
Pain 8
16. Your muscle spasms compared to prior to the operation? Pain 20
17. The amount of pain killers you need to take as compared to prior
to the operation?
Pain 29
18. Your ability to cope at home compared to prior to the operation? Effects of healthcare on
outcomes
21
19. Your appetite as compared to prior to the operation? Effects of healthcare on
outcomes
24, 25
20. Your mood compared to prior to the operation? Effects of healthcare on
outcomes
7, 18, 30
21. Your energy level compared to prior to the operation? Fatigue and sleep 2
22. Your sleep as compared to prior to the operation? Fatigue and sleep 2, 17, 21, 25, 26, 28, 30
23. How you feel overall compared to prior to the operation? Fatigue and sleep 9, 11, 17, 19
24. Your pain when trying to sleep compared to prior to the
operation?
Fatigue and sleep 17
25. Your ability to sleep through the night compared to prior to the
operation?
Fatigue and sleep 30
Strickland et al. Journal of Patient-Reported Outcomes            (2020) 4:91 Page 10 of 17
Four items were removed due to low loadings and be-
ing disliked by patients/being ambiguous. Reanalysis fol-
lowing item reduction by EFA produced the same four
factors resulting in similar variance (14 items) 69% and
loadings.
The dimensions of the OARS questionnaire displayed
good internal consistency and reliability with Cronbach’s
alpha ranging between .74–.89 (Table 7). Item-to-total
correlations are a measure of dimensionality and are also
presented in Table 7.
Oxford arthroplasty early change score (OACS)
EFA indicated that over 70% of the variance could be ex-
plained by two factors. Upon analysis of the data over
63% of the variance was explained by one factor. The
eigenvalue for the first factor was 13.207. The eigenvalue
for the second factor was very low (1.592) and the
amount of variance (7.6%) that was explained by the sec-
ond factor was also low. Inspection of the items
suggested that the two factors were primarily addressing
three separate issues of mobility, pain, and sleep.
The second factor did not appear to be meaningful,
and furthermore, the two separate factors did not appear
to be meaningful on their own (Table 8). Consequently,
it was decided to determine if a single forced-factor
would make the most parsimonious solution [36]. Re-
analysis of the remaining 14 items was performed fol-
lowing item reduction and similar variance and factor
loadings were found.
The OACS questionnaire displayed good internal
consistency and reliability with an overall Cronbach’s
alpha of .95. Item-to-total correlations are an additional
measure of test reliability and are also presented for the
OACS in Table 9. These analyses resulted in the final
OARS and OACS questionnaires, which now contain 14
items.
Internal consistency
Internal consistency for both the OARS and OACS were
good, with overall Cronbach’s alpha of 0.87 and 0.95 re-
spectively. Cronbach’s Alpha reliability analysis for items
loaded in each factor are presented (Tables 7 and 9).
Phase four
Out of the 158 approached, a total of 155 participants
were included in the study: 90 women (58%) and 65
men (42%). Response rates were 78–91%, with the mean
time to complete being approximately 6 min. Partici-
pants were again given both the OARS and OACS on
days 1, 2, 3, 7, 14 and 6 weeks. In addition, they received
SF-36 v2 Acute on days 7, 14 and 6 weeks.
Scale generation and testing scale properties
Both the overall 14-item OARS and domains of the
OARS were scored on a scale of zero to 100, with zero
being poor recovery and 100 being positive and indica-
tive of a good recovery. The OACS change measure was
also scored across a scoring range of 100, with minus 50
being much worse than before surgery, to 50, being
much better than before surgery. Zero indicates no
change.
Overall questionnaire scores for the OARS, OACS and
four OARS domain scores: pain; nausea and feeling un-
well; fatigue and sleep; and improving function and mo-
bility, can be seen in Tables 10, 11 and 12 respectively.
In the presence of missing data, scores were not im-
puted for these participants. As it is part of a validation
study, it is considered best practice to not impute data
when constructing and testing the measurement proper-
ties of a new instrument [29].
Table 6 Phase 3 18-item OARS day one item factor loadings
Rotated Component Matrixa
Component
1 2 3 4
OARS Item 6: I’ve had constant pain in the
affected area
.779 .078 .257 .213
OARS Item 5: It’s been painful in the affected
area
.774 .021 .248 .224
OARS Item 7: I’ve had pain at night in the
affected area
.768 .071 .276 .189
OARS Item 8: The affected area has felt
swollen
.665 .159 .002 .003
OARS Item 3: I’ve felt tired .576 .337 .037 −.147
OARS Item 17: I’ve been constipated .317 .263 .011 .042
OARS Item 16: I’ve felt woozy .027 .878 .032 .105
OARS Item 15: I’ve felt sick .086 .821 .123 .146
OARS Item 4: I’ve felt faint .120 .755 .063 .057
OARS Item 1: I’ve felt unwell .452 .614 .195 .114
OARS Item 2: I’ve felt disorientated .274 .542 .027 .170
OARS Item 18: I’ve lost my appetite .100 .540 .121 .339
OARS Item 13: I’ve found it difficult to sleep .114 .080 .919 .137
OARS Item 12: I’ve not slept well .141 .118 .911 .174
OARS Item 14: I’ve not been able to sleep due
to the pain in the affected area
.404 .152 .739 .169
OARS Item 10: I’ve not been able to stand .199 .178 .184 .857
OARS Item 11: I’ve not been able to walk −.059 .289 .264 .804
OARS Item 9: I’ve had difficulty getting into
bed
.462 .156 .056 .579
Extraction Method: Principal Component Analysis.
Rotation Method: Varimax with Kaiser Normalization.a
aRotation converged in 6 iterations
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Internal consistency reliability
In this final phase of testing, the OARS questionnaire
again displayed good internal consistency and reliability
with Cronbach’s alpha ranging between .77–.91. Simi-
larly, the OACS questionnaire displayed an overall Cron-
bach’s alpha of 0.93.
Responsiveness and sensitivity to change
The OACS questionnaire was designed to be a highly sen-
sitive change measure and as such was utilised for the pur-
pose of defining significant change in the OARS. The
OACS change measure was scored from negative 50, indi-
cating poor recovery, to positive 50, indication a good re-
covery. As this change measure is designed for and by the
early recovery joint replacement population, the OACS
measure is designed to assess change and, as it has
multiple items, it may be more granular than a single tran-
sition question [37, 38]. In order to estimate the minimally
important change in the OARS PROM score, the OACS
change measure results were reviewed by the expert
group. The group included a psychometrician with
Table 7 Phase three day 1 14 item OARS item to total







3. I’ve felt tired .434
5. It’s been painful in the
affected area
.647
7. I’ve had pain at night
in the affected area
.629







1. I’ve felt unwell .586
4. I’ve felt faint .561
15. I’ve felt sick .695




12. I’ve not slept well .853
13. I’ve found it difficult
to sleep
.829
14. I’ve not been able to








9. I’ve had difficulty
getting into bed
.501
10. I’ve not been able to
stand
.776
11. I’ve not been able to
walk
.659




OACS item 4: Your ability to walk compared to before the
operation?
.888 .318
OACS item 3: Your mobility compared to before the
operation?
.872 .354
OACS item 2: Your ability to move compared to before
the operation?
.871 .320
OACS item 5: Your ability to walk up stairs compared to
before the operation?
.865 .288
OACS item 6: Your ability to walk down stairs compared
to before the operation?
.859 .284
OACS item 1: Your ability to stand compared to before
the operation?
.841 .337
OACS item 9: Your pain in the affected area when
walking as compared to before the operation?
.735 .387
OACS item 14: Your ability to cope at home compared to
before the operation?
.684 .436
OACS item 10: Your pain in the affected area compared
to before the operation?
.671 .518
OACS item 12: Your pain when getting into bed
compared to before the operation?
.668 .482
OACS item 7: Your strength compared to before the
operation?
.645 .368
OACS item 8: How comfortable you feel when sitting
compared to before the operation?
.588 .514
OACS item 20: Your pain when trying to sleep compared
to before the operation?
.437 .766
OACS item 18: Your sleep compared to before the
operation?
.314 .755
OACS item 21: Your ability to sleep through the night
compared to before the operation?
.325 .751
OACS item 19: How you feel overall compared to before
the operation?
.476 .746
OACS item 16: Your mood compared to before the
operation?
.292 .728
OACS item 13: Your muscle spasms in the affected area
compared to before the operation?
.147 .701
OACS item 11: Your pain in the affected area at night
compared to before the operation?
.452 .678
OACS item 15: Your appetite compared to before the
operation?
.265 .629
OACS item 17: Your energy level compared to before the
operation?
.535 .586
Extraction Method: Principal Component Analysis.
Rotation Method: Varimax with Kaiser Normalization.a
aRotation converged in 6 iterations
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extensive experience and interest in PROMs, two consult-
ant arthroplasty surgeons and a surgical researcher. It was
determined that the change in score would be used to cal-
culate the minimally important change (MIC). It was de-
termined, as previously discussed, that a change of
between five and fifteen points out of 100, would indicate
‘minimal change’, with between five and minus five as ‘no
change’. OACS change scores for each patient were
reviewed between each testing time point. Patients that re-
ported a minimal change for the OACS at each change
time point were then grouped together and mean change
in the OARS scores calculated.
Change from ‘-5’ to ‘5’ was considered ‘no change’ and
change of between ‘-15’to ‘-5’ and ‘5’ to ‘15’ were consid-
ered minimal change. Participant responses were cate-
gorised at each time point and means calculated. OARS
scores were tested, both in aggregate (positive and nega-
tive change together, sign corrected), as discussed by
Guyatt [39, 40], and positive change only.
OACS change scores for each patient were reviewed
between each testing time point. Patients that reported a
minimal change for the OACS at each change time point
were then grouped together and mean change in the
OARS scores calculated. Mean change on the overall
OARS scores suggest that a minimal important change
(MIC) of approximately 13 points is significant to pa-
tients and of possible clinical significance too (Tables 13
and 14).
Construct validity
All correlations and dimensions were considered during
this process. Spearman rank-order correlation coeffi-
cients, or Spearman’s rho, were measured between the
dimensions of the OARS and SF-36v2 Acute (n = 142
participants) (Table 15). Moderate to strong correlations
were found between many of the previously hypothe-
sised domains of the OARS and SF-36v2 Acute. These
included correlations between OARS pain and SF-36v2
Acute bodily pain; OARS nausea and feeling unwell with
SF-36v2 Acute domains of general health and vitality;
OARS fatigue and sleep with SF-36v2 Acute vitality; and
OARS improving function and mobility with SF-36v2
Acute physical functioning. These associations were seen
between domains on all time points.
Discussion
In order to be considered as a valid measure, it is im-
portant that certain quality criteria are met and reported
Table 9 Phase three day 1 14 item OACS item to total
correlations and internal reliability





1. Your ability to stand compared to
before the operation?
.778
4. Your ability to walk compared to
before the operation?
.849
5. Your ability to walk up stairs
compared to before the operation?
.829
6. Your ability to walk down stairs
compared to before the operation?
.819
7. Your strength compared to before
the operation?
.714
8. How comfortable you feel when
sitting compared to before the
operation?
.742
10. Your pain in the affected area
compared to before the operation?
.801
9. Your pain in the affected area
when walking compared to before
the operation?
.784
15. Your appetite compared to
before the operation?
.597
16. Your mood compared to before
the operation?
.676
17. Your energy level compared to
before the operation?
.769
18. Your sleep compared to before
the operation?
.661
19. How you feel overall compared
to before the operation?
.810
20. Your pain when trying to sleep
compared to before the operation?
.756
Table 10 Mean overall scores for OARS testing time points
OARS day 1 OARS day 2 OARS day 3 OARS day 7 OARS day 14 OARS 6weeks
Mean 35.07 39.49 46.27 54.46 62.10 72.41
CI 31.47–38.67 35.96–43.03 43.36–49.17 51.66–57.27 59.13–65.07 69.32–75.49
N 141 146 143 138 134 126
SD 21.64 21.61 17.59 16.68 17.37 17.50
Range 98.21 94.64 91.07 91.07 80.36 80.36
Minimum 0.00 0.00 0.00 7.14 19.64 19.64
Maximum 98.21 94.64 91.07 98.21 100.00 100.00
CI 95% Confidence Interval, N Number, SD Standard deviation
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[17, 41]. The OARS and OACS have been developed
and assessed in accordance with these criteria [42].
The OARS and OACS are appropriate for the hip and
knee replacement population. The items have been de-
veloped and created directly from patient interviews and
their own words. These have been derived from the
qualitative interviews and themes that were confirmed
with patients following creation. The subject matter and
domains of items within the questionnaires have also
been confirmed with participants. Participants were gen-
erally positive in their assessment of the questionnaires
and were, in most cases, willing to take part. They re-
ported being keen to see how things had changed over
time. Thus, reaffirming that which the measures seek to
address.
Both the OARS and OACS received response rates of
78–91%. Patients reported it was not a burden with the
mean time to complete being approximately 6 min. Par-
ticipants stated that completing the questionnaires pro-
vided a welcome distraction from their surgical recovery
which was an unexpected finding as the questionnaires
primary focus is recovery and change since the time of
surgery. Returning the questionnaires in pre-paid enve-
lopes was reported as giving patients a reason to get up
and go to the post box during the early recovery period.
In addition, further work will include the measures being
transferred onto digital electronic delivery methods [43].
This will aid ease of delivery of the measures and facili-
tate receipt and processing of returned data.
The scores derived from both the OARS and OACS
have the potential to be meaningful in terms of the clin-
ical picture of recovery for patients at the group level,
and in relation to how the domain scores of the OARS
correlates to the scales of a generic health measure (SF-
36v2 Acute). The minimally important change (MIC) for
the OARS has been estimated and believed to be around
13 points. More work is required to fully explore and de-
fine clinically important differences and meaningful
change. In the future, results will be explored to refine
and define changes at the level of the individual.
The precision of the OARS and OACS has been dem-
onstrated in terms of robust psychometric testing in-
cluding exploratory factor analysis and removal of items
with floor/ceiling effects. Both the OARS and OACS
have demonstrated precision in their ability to distin-
guish between groups.
Table 11 Mean overall scores for OACS testing time points
OACS day 1 OACS day 2 OACS day 3 OACS day 7 OACS day 14 OACS 6weeks
Mean − 27.07 −22.42 −18.27 −13.81 −3.98 11.51
CI −30.02--24.13 −25.45--19.39 −20.80--15.74 −16.64--10.97 −7.40--0.57 7.78–15.24
N 125 124 131 127 121 121
SD 16.64 17.04 14.63 16.14 19.00 20.74
Range 80.36 76.79 73.21 78.57 89.29 91.07
Minimum −50.00 −50.00 −50.00 −48.21 − 44.64 −41.07
Maximum 30.36 26.79 23.21 30.36 44.64 50.00
CI 95% Confidence Interval, N Number, SD Standard deviation
Table 12 Mean domain scores for OARS
Day 1 Day 2 Day 3 Day 7 Day 14 6 weeks
Pain
Mean 25.04 27.32 30.99 35.09 42.55 55.18
N 149 148 145 140 135 128
SD 20.99 21.54 17.08 19.11 21.60 26.51
Range 100 93.75 87.5 93.75 100 93.75
Minimum 0 0 0 0 0 6.25
Maximum 100 93.75 87.5 93.75 100 100
Nausea and feeling unwell
Mean 44.83 46.90 55.17 68.66 78.47 86.12
N 150 149 145 140 135 127
SD 27.46 25.29 22.97 21.03 20.21 16.42
Range 100 100 100 87.5 81.25 93.75
Minimum 0 0 0 12.5 18.75 6.25
Maximum 100 100 100 100 100 100
Fatigue and sleep
Mean 32.72 39.43 46.35 50.00 50.18 63.16
N 150 149 146 141 136 126
SD 31.51 31.73 28.28 27.53 30.61 28.99
Range 100 100 100 100 100 100
Minimum 0 0 0 0 0 0
Maximum 100 100 100 100 100 100
Improving Function and Mobility
Mean 37.38 46.32 54.71 66.43 78.67 85.48
N 142 147 145 140 134 128
SD 30.07 26.82 23.89 21.16 17.08 16.24
Range 100 100 100 100 75 66.67
Minimum 0 0 0 0 25 33.33
Maximum 100 100 100 100 100 100
N Number, SD Standard deviation
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Both measures display good reliability testing for in-
ternal consistency with Cronbach’s alpha of between
0.77 and 0.93. An alpha of over 0.8 is desirable and it is
recommended that for measures being used at the level
of the individual, a higher Cronbach’s alpha of 0.9 is rec-
ommended. Reproducibility, in terms of test re-test, is
not feasible because of the very nature of the work
within this area of research, as patients are experiencing
a sustained period of constant change and, hopefully,
improvement during these 6 weeks.
Further testing of these questionnaires at the level of
the individual is planned, which could provide evidence
for their use in routine clinical care and assessment. In
addition, further work investigating methods and cut-
points to interpret change scores that are meaningful to
patients, and not just clinicians, is needed and is cur-
rently underway. The measures are available for paper
and pen completion and through digital electronic deliv-
ery methods. This will aid ease of delivery of the mea-
sures and facilitate receipt and processing of returned
data. These questionnaires will now be used in both ob-
servational studies and clinical trials. This work will en-
able the next stage of important work using the measure
to define and assess an optimal-recovery protocol for
lower limb joint replacement.
Further testing of these questionnaires at the level of
the individual in patient pathways and clinical research
could bring real results to patients, healthcare providers,
hospital trusts and clinical commissioning groups. These
questionnaires will now go on to be used in both
research studies and clinical trials. The research com-
pleted in this paper will now enable the next stage of im-
portant work using these measures to define and assess
of an optimal-recovery protocol for lower limb joint
replacement.
Healthcare providers and hospital bodies must con-
tinue work to progress and optimise the patient recovery
pathway. Many areas could still be developed and there-
fore continue to make marked improvements for pa-
tients. Research using validated measures provides the
opportunity, in combination with already used PROMS
and patient data, to continue to make strides in recovery,
patient satisfaction and outcomes.
Routine use of the new PROM and change measure
could facilitate benchmarking and audit within the clin-
ical area. In addition, potential research uses for these
tools could include studies to evaluate improving post-
operative pain regimens.
Being able to identify exactly what components are be-
ing utilised and making a difference in the private versus
NHS setting could greatly improve the patient popula-
tions. This, in turn, has the potential to positively affect
outcomes for both the National Health Service (NHS)
and greater patient populations.
The promising measurement properties of the OARS
and OACS, their relevance to patients, clinicians and
other stakeholders, make them the ideal measurements
to be used in randomised controlled trials that assess the
efficiency of different interventions in this increasing pa-
tient population.
Table 13 Mean overall ‘some change’ aggregate OARS scores
Some change aggregate day 1–2 day 2–3 day 3–7 day 7–14 day 14–6 weeks
Mean 8.53 15.21 12.05 10.16 14.23
CI 7.44–9.62 11.63–18.79 10.14–13.97 8.18–12.15 10.73–17.74
N 36 33 56 52 33
SD 3.23 10.09 7.14 7.12 9.89
Range 12.50 33.93 26.79 26.79 41.07
Minimum 1.79 0.00 1.79 0.00 0.00
Maximum 14.29 33.93 28.57 26.79 41.07
CI 95% Confidence Interval, N Number, SD Standard deviation
Table 14 Mean overall ‘some positive change’ OARS scores
Some positive change day 1–2 day 2–3 day 3–7 day 7–14 day 14–6 weeks
Mean 8.63 16.57 12.55 10.76 15.27
CI 7.36–9.90 12.33–20.81 10.12–14.97 8.36–13.16 11.44–19.10
N 24 25 38 40 29
SD 3.01 10.28 7.37 7.52 10.06
Range 8.93 33.93 26.78 26.79 41.07
Minimum 5.36 0.00 1.79 0.00 0.00
Maximum 14.29 33.93 28.57 26.79 41.07
CI 95% Confidence Interval, N Number, SD Standard deviation
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Conclusion
An early recovery tool, the Oxford Arthroplasty Early
Recovery Score (OARS), and a change measure, the Ox-
ford Arthroplasty Early Change Score (OACS), have
been developed. The OARS and OACS have been tested
and validated in accordance with FDA guidelines [9] and
best practice. They have been validated for use in the
first 6 weeks following UKA, TKA and THA. Initial psy-
chometric testing has shown some positive results, valid-
ity and sensitivity to change.
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Pain Correlation .388 .285 .505 .407 .443 .349 .410 .453
Nausea and feeling
unwell
Correlation .259 .262 .226 .367 .409 .255 .359 .402
Fatigue and sleep Correlation .269 .355 .454 .249 .420 .368 .368 .358
Improving function
and mobility




Pain Correlation .426 .412 .556 .331 .497 .458 .460 .479
Nausea and feeling
unwell
Correlation .287 .298 .398 .380 .444 .287 .379 .438
Fatigue and sleep Correlation .278 .322 .477 .231 .376 .332 .311 .355
Improving function
and mobility




Pain Correlation .481 .454 .659 .318 .569 .490 .468 .497
Nausea and feeling
unwell
Correlation .379 .400 .403 .387 .573 .369 .488 .499
Fatigue and sleep Correlation .403 .432 .536 .262 .604 .406 .353 .422
Improving function
and mobility
Correlation .486 .517 .537 .370 .437 .419 .413 .394
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